Bivalirudin
Product manufactured by Hospira, Inc.
Indications and Purposes
| 1 Indications And Usage Bivalirudin Is Indicated For Use As An Anticoagulant For Use In Patients Undergoing Percutaneous Coronary Intervention (Pci) Including Patients With Heparin-Induced Thrombocytopenia And Heparin-Induced Thrombocytopenia And Thrombosis Syndrome. Bivalirudin Is A Direct Thrombin Inhibitor Indicated For Use As An Anticoagulant In Patients Undergoing Percutaneous Coronary Intervention (Pci) Including Patients With Heparin-Induced Thrombocytopenia (Hit) Or Heparin-Induced Thrombocytopenia And Thrombosis Syndrome (Hitts).( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Bivalirudin |